MCI
MRTX

McDonald Capital Investors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

McDonald Capital Investors’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,250
Closed -$250K – 23
2023
Q4 		$250K Buy
+4,250
New +$239K 0.02% 22

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

McDonald Capital Investors's MRTX Position: Q1 2024 in Review

McDonald Capital Investors sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 4,250 shares — an estimated $250K sold.

McDonald Capital Investors first reported a position in MRTX in Q4 2023 and held it in 1 quarter. The position peaked at $250K in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • McDonald Capital Investors reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • McDonald Capital Investors sold 4,250 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $250K.
  • McDonald Capital Investors first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • McDonald Capital Investors's Mirati Therapeutics, Inc. Common Stock position peaked at $250K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on McDonald Capital Investors's 13F filing for Q1 2024, filed 3 May 2024.